A second pedigree with autosomal dominant nemaline myopathy caused by TPM3 mutation: a clinical and pathological study. - Inserm - Institut national de la santé et de la recherche médicale Accéder directement au contenu
Article Dans Une Revue Neuromuscular Disorders Année : 2007

A second pedigree with autosomal dominant nemaline myopathy caused by TPM3 mutation: a clinical and pathological study.

Résumé

The slow alpha-tropomyosin (TPM3) gene has to date been associated with few cases of both dominant and recessive nemaline myopathies. We report the identification of a p.Arg167His mutation in a four-generation family presenting with a mild classical form of the disease. Clinically, there was no correlation between the age at presentation and the severity of the disease. The dominant-negative p.Arg167His mutation is a recurrent mutation, previously reported in one sporadic case. Histological studies showed discrepancy between the two reports. While a type II fibre predominance was described in the sporadic case, we observed an almost complete type I fibre predominance. This study emphasizes the variability in histopathological phenotypes seen with TPM3 mutations.
Fichier sous embargo
Fichier sous embargo
Date de visibilité indéterminée
Loading...

Dates et versions

inserm-00381952 , version 1 (08-07-2009)

Identifiants

Citer

Isabelle Pénisson-Besnier, Nicole Monnier, Annick Toutain, Frédéric Dubas, Nigel G. Laing. A second pedigree with autosomal dominant nemaline myopathy caused by TPM3 mutation: a clinical and pathological study.. Neuromuscular Disorders, 2007, 17 (4), pp.330-7. ⟨10.1016/j.nmd.2007.01.017⟩. ⟨inserm-00381952⟩
95 Consultations
2 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More